BLUE SHIELD OF CALIFORNIA JUNE 2016 PLUS DRUG FORMULARY CHANGES

Similar documents
South Carolina Department of Health and Human Services Post Office Box 8206 Columbia, South Carolina

Relative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*

UF Decision Report FY06-07 Beneficiary Advisory Panel 10 Jan 2008

Central Nervous System Stimulants Drug Class Prior Authorization Protocol

GA KS KY LA MD NJ NV NY TN TX WA Applicable X N/A N/A X N/A X X X X X X N/A N/A X *FHK- Florida Healthy Kids. ADHD Narcolepsy

Pharmacy Benefit Management (PBM) Program FORMULARY/PRODUCT RESTRICTIONS

Oregon Health Plan prescription benefit updates

PHARMACY COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 3/15/18 SECTION: DRUGS LAST REVIEW DATE: 3/15/18 LAST CRITERIA REVISION DATE: ARCHIVE DATE:

35 mg NF -- Dextroamphetamine Sulfate IR Tablets: Zenzedi IR Ttablets: Dextroamphetamine Sulfate ER Capsules: 15 mg ProCentra Solution.

UnitedHealthcare Pharmacy Clinical Pharmacy Programs. Program Number 2017 P Prior Authorization/Notification CNS Stimulants

QUANTITY LIMIT CRITERIA

ADHD Medications Table

Clinical Policy: Atomoxetine (Strattera) Reference Number: CP.PST.17 Effective Date:

Proton Pump Inhibitors (PPIs) (Sherwood Employer Group)

Pharmacy Coverage Guidelines are subject to change as new information becomes available.

Pharmacy Prior Authorization Clinical Guideline for Attention Deficit Disorder/Attention Deficit Hyperactivity CNS Stimulants

OVERVIEW FOOD AND DRUG ADMINISTRATION-APPROVED INDICATIONS

Proton Pump Inhibitors. Description

Judges Reference Table for the March 2016 Psychotropic Medication Utilization Parameters for Foster Children

Proton Pump Inhibitors

Attention Deficit Hyperactivity Disorder (ADHD) in Children under Age 6

ADHD STIMULANTS-S(SHC)

Amphetamines

Proton Pump Inhibitors. Description. Section: Prescription Drugs Effective Date: July 1, 2014

Drug Class Monograph

Your prescription benefit updates Formulary Updates - Effective January 1, 2019

Commissioner for the Department for Medicaid Services Selections for Preferred Products

Step Therapy Approval Criteria

Step Therapy Approval Criteria

Proton Pump Inhibitors Drug Class Prior Authorization Protocol

Pharmacy Medical Necessity Guidelines: ADHD CNS Stimulant Medications

ADHD Stimulant Step Therapy Program

DOD PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL

SmithRx Standard Formulary Step Therapy List

AD/HD is a mental disorder, and it often lasts from

Cholesterol. Medicines To Help You

MAXIMUM ALLOWABLE COST POLICY CHANGES DECEMBER 5, 2016 QUESTIONS AND ANSWERS

Cerebral Stimulant and ADHD Drugs Prior Authorization Request

Pharmacy Medical Necessity Guidelines: ADHD CNS Stimulant Medications

1/1/2019 FORMULARY CHANGES CIGNA COMMERCIAL CUSTOMERS

Generics. Lead with. P r e s c r i p t i o n S t e p T h e r a p y P r o g r a m

Rpts. GENERAL General Schedule (Code GE) Program Prescriber type: Dental Medical Practitioners Nurse practitioners Optometrists Midwives

Amphetamines

Pharmacy Medical Necessity Guidelines: CNS Stimulant Medications

Avoid paying too much for your prescriptions

Big Lots Behavioral Health. Prescribing Guidelines for Behavioral Health

Focalin compared to concerta

Commercial Formulary and Utilization Management Program Updates for January 2017 Producer Communication #782 Issued November 10, 2016

Pharmacy Updates Summary

Big Lots Behavioral Health. Prescribing Guidelines for Behavioral Health

Prescription benefit updates Large group

Behavioral Health. Behavioral Health. Prescribing Guidelines

Omeprazole 10mg. Name, Restriction, Manner of administration and form OMEPRAZOLE omeprazole 10 mg enteric tablet, 30 (8332M) Max. Qty.

Parents Guide to ADHD Medications. Copyright Child Mind Institute

Conversion from focalin xr to vyvanse

Drug Class Review. Pharmacologic Treatments for Attention Deficit Hyperactivity Disorder

ADHD Medications: Basics. David Benhayon MD, PhD

Stimulants. The psychostimulants, or more simply known as stimulants, are used primarily in treating attention-deficit/ Dosing Information

Clinical Policy: CNS Stimulants Reference Number: CP.PMN.92 Effective Date: Last Review Date: Line of Business: Commercial, Medicaid

Facts about ADHD drugs as treatment

Methylphenidate also has an off-label indication for depression, although published trials are limited in size and duration (14).

Cost Effectiveness Recommendations For Kentucky Retirement Systems MTM Plan 2011

Difference between omeprazole and omeprazole delayed release

Dose Range. Dose Schedule. Child: 5-60 mg Over 50 kg:5-100 mg Focalin, child: mg Over 50 kg: mg. Focalin: 4-5 hrs.

Clinical Policy: CNS Stimulants Reference Number: CP.PMN.XX Effective Date: Last Review Date: Line of Business: Commercial, Medicaid

See Important Reminder at the end of this policy for important regulatory and legal information.

OHIO MEDICAID PHARMACY COVERAGE

SUMAVEL DOSEPRO (sumatriptan succinate) solution for injection

Drug Guide. April New Specialty Drug Approvals. New Formulations for Existing Drugs

Attention: Behavioral Health Providers, Pharmacists and Prescribers N.C. Medicaid and N.C. Health Choice Preferred Drug List Changes - UPDATE

The Weekly Mortar & Pestle

See Important Reminder at the end of this policy for important regulatory and legal information.

Methylphenidate Dexmethylphenidate

Pharmacy Updates Summary

Step Therapy Medications

Rationale for Decision Excluded Generic OTC equivalent available (Flonase Allergy Relief) Medicare status (if differs)

Nexium 24HR. Tools and information for you and your pharmacy team NOW OTC FOR FREQUENT HEARTBURN. Consumer Healthcare Pfizer Inc.

Rpts. GENERAL General Schedule (Code GE)

2015 Chinese Community Health Plan Senior Program (HMO) Step Therapy Criteria Last Updated 11/1/2015

Update to HMO Drug Formulary Tier Definitions. February 8, 2018

Methylphenidate Dexmethylphenidate

ARBS MEDICATION(S) SUBJECT TO STEP THERAPY DIOVAN HCT MG TAB, DIOVAN HCT MG TABLET

March 2018 P & T Updates

WHO YOU ARE IS IMPORTANT. ESPECIALLY ON THE INSIDE. Ask your healthcare provider if one-pill, once-a-day ODEFSEY is right for you.

A REVIEW OF STIMULANTS FOR ADHD FOR THE PRIMARY CARE PROVIDER JAMES C. ASHWORTH MD MEDICAL DIRECTOR UNIVERSITY OF UTAH NEUROPSYCHIATRIC INSTITUTE

Pharmacy benefit guide

Half life of focalin xr

Generics. Lead with. Prescription Step Therapy Program

Quarterly pharmacy formulary change notice

Off Label Uses: Amphetamines can be used as adjunctive therapy in the treatment of resistant depression (9).

ANTINEOPLASTIC DRUGS CHAPTER 21. Antineoplastic drugs - designed to treat malignancies, now also used to treat diseases with inflammatory component

Alameda Alliance for Health Pharmacy & Therapeutics (P&T) Committee Decisions

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.

Pain Oral-Intranasal Fentanyl (Abstral, Actiq, Fentora, Lazanda, Onsolis, Subsys)

THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM

Quarterly pharmacy formulary change notice

Attention Deficit Hyperactivity Disorder: Comparison of Medication Efficacy and Cost

Save on your drugs with HealthyRx

Date: October 3, 2017 To: Participating Providers From: YourCare Health Plan Provider Relations Subject: 2018 Formulary Changes

Transcription:

BLUE SHIELD OF CALIFORNIA JUNE 2016 PLUS DRUG FORMULARY CHANGES Blue Shield is committed to covering safe, effective and affordable medications, so we regularly review and update our drug formularies. Our Pharmacy and Therapeutics (P&T) Committee is made up of a group of practicing physicians and pharmacists who meet quarterly to recommend changes to our formulary based on the latest medical literature, new clinical guidelines, new information from key physician experts, and new information from the Food and Drug Administration. Changes to the Plus Drug Formulary from the P&T Committee meeting are outlined below. To view a copy of the Plus Drug Formulary, please download a copy. The drugs listed below are to be used for FDA-approved indications but may also be used for other conditions. 1. DRUGS ADDED TO FORMULARY The following drugs were added to the formulary: Drug FDA Indication(s) Coverage Restriction(s) Descovy HIV infection Odefsey HIV infection Viagra Erectile dysfunction Prior authorization. Gender limit.. 2. FORMULARY DRUGS WITH CHANGES TO RESTRICTIONS The following drugs remain at their current formulary status but have new coverage restriction(s) as Drug FDA Indication(s) New Restriction(s) doxycycline delayed-release (generic Doryx) amlodipine-atorvastatin (generic Caduet) fluvastatin (generic Lescol, Lescol XL) quazepam (generic Doral) Proton Pump Inhibitors (PPIs) esomeprazole (generic Nexium) 40mg capsule Bacterial infection Hypertension, CAD, Hyperlipidemia triglyceride, Prevent heart attack or stroke Insomnia Gastric and Duodenal ulcer, GERD, Zollinger-Ellison syndrome Prior authorization. Prior authorization Prior authorization Prior authorization if 65 years of age or older. Prior authorization Page 1 of 5

Drug FDA Indication(s) New Restriction(s) omeprazole-sodium bicarbonate (generic Zegerid) 40mg capsule rabeprazole (generic Aciphex) Gastric and Duodenal ulcer, GERD, Esophagitis, Stress gastritis Duodenal ulcer, GERD, Esophagitis, H.pylori, Zollinger- Ellison syndrome Prior authorization Prior authorization Fenofibrates and Fibric Acid Derivatives fenofibrate 43mg, 130mg fenofibrate (generic Fenoglide) Medications and Stimulants for dexmethylphenidate extendedrelease (generic Focalin XR) dextroamphetamine tablet (generic Dexedrine) dextroamphetamine extendedrelease (generic Dexedrine Spansule) methamphetamine (generic Desoxyn) methylphenidate oral solution (generic Methylin) methylphenidate CD (generic Metadate CD) triglyceride triglyceride, Narcolepsy, Narcolepsy, Obesity, Narcolepsy methylphenidate er 10mg, 20mg, Narcolepsy The following drugs remain at their current formulary status but have coverage restriction(s) removed as Drug FDA Indication(s) Restriction removed guanfacine er (generic Intuniv) requirement lamivudine (generic Epivir HBV) tablet Hepatitis B Prior authorization requirement Epivir HBV solution Hepatitis B Prior authorization requirement 3. NON-FORMULARY DRUGS WITH CHANGES TO RESTRICTIONS Page 2 of 5

The following drugs remain at their current formulary status but have new coverage restriction(s) as Drug FDA Indication(s) New Restriction(s) Formulary Alternative(s) Antara High cholesterol and triglyceride nanocrystallized fenofibrate (generic Tricor), micronized fenofibrate (lofibra), fenofibric acid choline (generic Trilipix), fenofibric acid (generic Fibricor), gemfibrozil (generic Lopid) Seconal sodium Insomnia Triglide High cholesterol and triglyceride nanocrystallized fenofibrate (generic Tricor), micronized fenofibrate (lofibra), fenofibric acid choline (generic Trilipix), fenofibric acid (generic Fibricor), gemfibrozil (generic Lopid) Zegerid powder for suspension Gastric and Duodenal ulcer, GERD, Esophagitis, Stress gastritis Prior authorization lansoprazole, omeprazole, pantoprazole Medications and Stimulants for Aptensio XR Daytrana Dyanavel XR Evekeo, Narcolepsy dextroamphetamineamphetamine (generic Adderall), dexmethylphenidate (generic Focalin), methylphenidate (generic Methylin, Ritalin) Focalin XR 25mg, 35mg Metadate CD 20mg, 30mg, 40mg Zenzedi, Narcolepsy dextroamphetamineamphetamine (generic Adderall), dexmethylphenidate (generic Focalin), methylphenidate (generic Methylin, Ritalin) 4. DRUGS REMOVED FROM THE FORMULARY Page 3 of 5

The following drugs were moved from Formulary to Non-formulary: Drug FDA Indication(s) Restriction(s) Formulary Alternative(s) One Touch blood glucose test strips Proair HFA, Proair Respimat Sumavel Dosepro Test blood glucose Bronchospasm Migraine Prior Authorization... Accu-chek blood glucose test strips Ventolin HFA sumatriptan vial, prefilled syringe, prefilled cartridge The following brand-name drug was removed from the formulary because generic is now available and was added to the formulary: Brand-name Drug FDA Indication(s) Restriction(s) Formulary Alternative Crestor Nasonex Tegretol XR 100mg triglyceride, Reduce stroke or heart attack, Slow atherosclerosis Allergic rhinitis Seizures, Trigeminal neuralgia. rosuvastatin fluticasone nasal carbamazepine extended-release 5. DRUGS ADDED TO THE SPECIALTY TIER The following drugs were added to the Blue Shield specialty tier: Specialty Drug Cabometyx Impavido Nuplazid Taltz Venclexta Vistogard Coverage Restriction(s) Prior authorization.. Prior authorization.. Prior authorization.. Prior authorization.. Prior authorization.. Prior authorization.. The following drugs remain at their current formulary status but have new coverage restriction(s) as Drug FDA Indication(s) New Restriction(s) Preferred Alternative(s) Avonex Page 4 of 5

Drug FDA Indication(s) New Restriction(s) Preferred Alternative(s) Glatopa Rebif, Rebif Rebidose Prior authorization The following drugs remain at their current formulary status but have coverage restriction(s) removed as Drug FDA Indication(s) Restriction removed Extavia Prior authorization requirement Gilenya Prior authorization requirement 6. DRUGS REMOVED FROM COVERAGE The following drug was excluded from coverage because it is available without a prescription: Prescription Drug budesonide nasal (Rhinocort Aqua) Non-prescription Drug Rhinocort Allergy The following drugs were excluded from coverage because they are not approved by the Food and Drug Administration (FDA): Drug Animi-3 Corvite Enlyte Strovite One Drug Corvite Free Corvita Multivitamins-A, B, D, E, K, Z VC Forte, Vic Forte Page 5 of 5